Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | PRKDC | P78527 | 2/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5029887 | 0.97 | ALOX5 (0.36) | ALOX5PRKDCGGPS1 | |
| SCHEMBL14949491 | 0.91 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL12925698 | 0.91 | ALOX5 (0.39) | ALOX5PRKDCGGPS1PRMT5WDR77 | |
| SCHEMBL5028299 | 0.89 | MAPK14 (0.32) | ALOX5PRKDC | |
| SCHEMBL16919802 | 0.88 | MAPK14 (0.32) | ALOX5PRKDC | |
| SCHEMBL14849210 | 0.88 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PRMT5WDR77 | |
| SCHEMBL5028288 | 0.88 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PRMT5WDR77 | |
| SCHEMBL5029690 | 0.88 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PRMT5WDR77 | |
| SCHEMBL10092199 | 0.88 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PRMT5WDR77 | |
| SCHEMBL17264912 | 0.88 | TSHR (0.32) | NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130119360-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | MERCK PATENT GMBH (DE) | 2013-05-16 | — | — | US | disclosed |
| US-8367224-B2 | Organic electroluminescence element, new compound for the same, display device and lighting device using the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-05 | — | — | US | disclosed |
| EP-2453496-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE | Konica Minolta Holdings, Inc. (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006670-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME | AOC2, AOC3, CDYL | ALOX5 855/4885PRKDC 3081/4885GGPS1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.